JPMorgan lowered the firm’s price target on DocuSign (DOCU) to $77 from $81 and keeps a Neutral rating on the shares. The company’s fiscal Q1 results were dragged down by an “uncharacteristic” billings miss and downward fiscal 2026 billings outlook revision on lower early renewals, the analyst tells investors in a research note.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOCU:
- DocuSign price target lowered to $80 from $85 at UBS
- DocuSign price target lowered to $85 from $93 at Baird
- DocuSign price target lowered to $86 from $92 at Morgan Stanley
- DocuSign’s Transitional Challenges and Strategic Investments Lead to Hold Rating
- DocuSign price target raised to $67 from $65 at Wells Fargo